Elevance Health, Inc. (LON:0HG8)
London · Delayed Price · Currency is GBP · Price in USD 344.74
+0.75 (0.22%)
At close: Jan 30, 2026
Elevance Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Premiums & Annuity Revenue | 164,639 | 144,166 | 142,854 | 133,229 | 117,373 |
Total Interest & Dividend Income | 2,194 | 2,051 | 1,825 | 1,485 | 1,378 |
Other Revenue | 32,292 | 30,593 | 26,661 | 21,885 | 19,892 |
| 199,125 | 176,810 | 171,340 | 156,599 | 138,643 | |
Revenue Growth (YoY) | 12.62% | 3.19% | 9.41% | 12.95% | 13.76% |
Policy Benefits | 148,223 | 127,567 | 124,330 | 116,642 | 102,571 |
Amortization of Goodwill & Intangibles | 628 | 580 | 885 | 767 | 441 |
Selling, General & Administrative | 41,940 | 39,466 | 36,236 | 30,728 | 26,604 |
Total Operating Expenses | 190,791 | 167,613 | 161,451 | 148,137 | 129,616 |
Operating Income | 8,334 | 9,197 | 9,889 | 8,462 | 9,027 |
Interest Expense | -1,402 | -1,185 | -1,030 | -855 | -802 |
EBT Excluding Unusual Items | 6,932 | 8,012 | 8,859 | 7,607 | 8,225 |
Merger & Restructuring Charges | -198 | -268 | -752 | -7 | -202 |
Gain (Loss) on Sale of Assets | - | 201 | - | - | - |
Asset Writedown | - | -41 | -392 | - | -7 |
Legal Settlements | -24 | - | - | - | - |
Other Unusual Items | - | - | - | - | -21 |
Pretax Income | 6,710 | 7,904 | 7,715 | 7,600 | 7,995 |
Income Tax Expense | 1,049 | 1,933 | 1,724 | 1,712 | 1,846 |
Earnings From Continuing Ops. | 5,661 | 5,971 | 5,991 | 5,888 | 6,149 |
Minority Interest in Earnings | 1 | 9 | -4 | 6 | 9 |
Net Income | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 |
Net Income to Common | 5,662 | 5,980 | 5,987 | 5,894 | 6,158 |
Net Income Growth | -5.32% | -0.12% | 1.58% | -4.29% | 34.69% |
Shares Outstanding (Basic) | 225 | 232 | 236 | 240 | 244 |
Shares Outstanding (Diluted) | 225 | 233 | 237 | 243 | 247 |
Shares Change (YoY) | -3.56% | -1.90% | -2.22% | -1.62% | -2.95% |
EPS (Basic) | 25.21 | 25.81 | 25.38 | 24.56 | 25.26 |
EPS (Diluted) | 25.21 | 25.68 | 25.22 | 24.28 | 24.95 |
EPS Growth | -1.83% | 1.82% | 3.87% | -2.69% | 38.77% |
Free Cash Flow | 3,174 | 4,552 | 6,765 | 7,247 | 7,277 |
Free Cash Flow Per Share | 14.13 | 19.55 | 28.50 | 29.85 | 29.48 |
Dividend Per Share | 6.840 | 6.520 | 5.920 | 5.120 | 4.520 |
Dividend Growth | 4.91% | 10.13% | 15.63% | 13.27% | 18.95% |
Operating Margin | 4.18% | 5.20% | 5.77% | 5.40% | 6.51% |
Profit Margin | 2.84% | 3.38% | 3.49% | 3.76% | 4.44% |
Free Cash Flow Margin | 1.59% | 2.57% | 3.95% | 4.63% | 5.25% |
EBITDA | 9,880 | 9,856 | 10,949 | 9,538 | 9,844 |
EBITDA Margin | 4.96% | 5.57% | 6.39% | 6.09% | 7.10% |
D&A For EBITDA | 1,546 | 659 | 1,060 | 1,076 | 817 |
EBIT | 8,334 | 9,197 | 9,889 | 8,462 | 9,027 |
EBIT Margin | 4.18% | 5.20% | 5.77% | 5.40% | 6.51% |
Effective Tax Rate | 15.63% | 24.46% | 22.35% | 22.53% | 23.09% |
Revenue as Reported | 199,125 | 177,011 | 171,340 | 156,595 | 138,639 |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.